Antisoma (ASM)

[califax]

Notification of Preliminary Results

Date : 07/20/2010 @ 5:00AM
Source : UK Regulatory (RNS & others)
Stock : Antisoma (ASM)

http://ih.advfn.com/p.php?pid=nmona&article=43662614&symbol=L^ASM

London, UK, and Cambridge, MA: 20 July 2010 - Antisoma plc (LSE: ASM; USOTC: ATSMY) will be announcing its Preliminary Results for the year ended 30 June 2010 on Thursday 29 July 2010.


Enquiries:

Daniel Elger
VP, Marketing & Communications
Antisoma plc
[phone]

Mark Court/Lisa Baderoon/Catherine Breen
Buchanan Communications
[phone]

Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visitwww.antisoma.com for further information about Antisoma.


[HUG#1432737]


This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Antisoma plc via Thomson Reuters ONE